Finzati - Logo
COCP logo

Cocrystal Pharma, Inc.

COCP • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$15.17M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.24Healthy liquidity · 3.68Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$15.17M
52W Range0.76 - 2.67
Beta1.43
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.24
Current Ratio3.68
Quick Ratio3.68
Volume35.92K

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
89/100
Why this score▼
Manageable debt level · 0.24Healthy liquidity · 3.68Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 2/22/2012
Industry: Biotechnology
P/B i: 1.75
Debt / Equity i: 0.24
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.24
Current Ratio: 3.68
Quick Ratio: 3.68
Status: Good

Insider Transactions

Recent executive and insider activity

FROST PHILLIP MD ET AL
Transaction: 08/05/2026
BUY
Change
+10,000
Price
$0.98
Filing
08/06/2026
Type
BUY
FROST PHILLIP MD ET AL
Transaction: 08/03/2026
BUY
Change
+75,000
Price
$0.94
Filing
08/05/2026
Type
BUY
SAPIRSTEIN JAMES
Transaction: 06/03/2026
OTHER
Change
0
Price
Not reported
Filing
06/03/2026
Type
OTHER